☆ 4.5 Article

Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE):: Discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1′ substituents

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

获取全文
添加到收藏夹

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 18, 期 6, 页码 1958-1962

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2008.01.120

关键词

TACE inhibitors; MMP inhibitors

类别

Chemistry, Medicinal Chemistry, Organic

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

Potent and selective inhibitors of tumor necrosis factor-a converting enzyme ( TACE) were discovered with several new heterocyclic P1' groups in conjunction with cyclic beta-amino hydroxamic acid scaffolds. Among them, the pyrazolopyridine provided the best overall profile when combined with tetrahydropyran beta-amino hydroxamic acid scaffold. Specifically, inhibitor 49 showed IC50 value of 1 nM against porcine TACE and 170 nM in the suppression of LPS-induced TNF-alpha of human whole blood. Compound 49 also displayed excellent selectivity over a wide panel of MMPs as well as excellent oral bioavailability (F% > 90%) in rat n-in-1 PK studies. (C) 2008 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Improving the Pharmacokinetic and CYP Inhibition Profiles of Azaxanthene-Based Glucocorticoid Receptor Modulators-Identification of (S)-5-(2-(9-Fluoro-2-(4-(2-hydroxypropan-2-yl)phenyl)-5H-chromeno[2,3-b]pyridin-5-yl)-2-methylpropanamido)-N-(tetrahydro-2H-pyran-4-yl)-1,3,4-thiadiazole-2-carboxamide (BMS-341)

Michael G. Yang, T. G. Murali Dhar, Zili Xiao, Hai-Yun Xiao, James J. -W. Duan, Bin Jiang, Michael A. Galella, Mark Cunningham, Jinhong Wang, Sium Habte, David Shuster, Kim W. McIntyre, Julie Carman, Deborah A. Holloway, John E. Somerville, Steven G. Nadler, Luisa Salter-Cid, Joel C. Barrish, David S. Weinstein

JOURNAL OF MEDICINAL CHEMISTRY (2015)

添加到收藏夹
Article Chemistry, Medicinal

Identification of bicyclic hexafluoroisopropyl alcohol sulfonamides as retinoic acid receptor-related orphan receptor gamma (RORγ/RORc) inverse agonists. Employing structure-based drug design to improve pregnane X receptor (PXR) selectivity

Hua Gong, David S. Weinstein, Zhonghui Lu, James J. -W. Duan, Sylwia Stachura, Lauren Haque, Ananta Karmakar, Hemalatha Hemagiri, Dhanya Kumar Raut, Arun Kumar Gupta, Javed Khan, Dan Camac, John S. Sack, Andrew Pudzianowski, Dauh-Rurng Wu, Melissa Yarde, Ding-Ren Shen, Virna Borowski, Jenny H. Xie, Huadong Sun, Celia D'Arienzo, Marta Dabros, Michael A. Galella, Faye Wang, Carolyn A. Weigelt, Qihong Zhao, William Foster, John E. Somerville, Luisa M. Salter-Cid, Joel C. Barrish, Percy H. Carter, T. G. Murali Dhar

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)

添加到收藏夹
Article Chemistry, Medicinal

Discovery of beta-benzamido hydroxamic acids as potent, selective, and orally bioavailable TACE inhibitors

James J. -W. Duan, Lihua Chen, Zhonghui Lu, Chu-Biao Xue, Rui-Qin Liu, Maryanne B. Covington, Mingxin Qian, Zelda R. Wasserman, Krishna Vaddi, David D. Christ, James M. Trzaskos, Robert C. Newton, Carl P. Decicco

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

添加到收藏夹
Article Chemistry, Medicinal

α,β-Cyclic-β-benzamido hydroxamic acids:: Novel oxaspiro[4.4] nonane templates for the discovery of potent, selective, orally bioavailable inhibitors of tumor necrosis factor-α converting enzyme (TACE)

Gregory R. Ott, Naoyuki Asakawa, Rui-Qin Liu, Maryanne B. Covington, Mingxin Qian, Krishna Vaddi, Robert C. Newton, James M. Trzaskos, David D. Christ, Laurine Galya, Thomas Scholz, Will Marshall, James J. -W. Duan

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

添加到收藏夹
Article Chemistry, Medicinal

Potent, exceptionally selective, orally bioavailable inhibitors of TNF-α Converting Enzyme (TACE):: Novel 2-substituted-1H-benzo[d]imidazol-1-yl)methyl)benzamide P1′ substituents

Gregory R. Ott, Naoyuki Asakawa, Zhonghui Lu, Rajan Anand, Rui-Qin Liu, Maryanne B. Covington, Krishna Vaddi, Mingxin Qian, Robert C. Newton, David D. Christ, James M. Trzaskos, James J. -W. Duan

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

添加到收藏夹
Article Chemistry, Medicinal

α,β-cyclic-β-benzamido hydroxamic acids:: Novel templates for the design, synthesis, and evaluation of selective inhibitors of TNF-α converting enzyme (TACE)

Gregory R. Ott, Naoyuki Asakawa, Zhonghui Lu, Rui-Qin Liu, Maryanne B. Covington, Krishna Vaddi, Mingxin Qian, Robert C. Newton, David D. Christ, James M. Traskos, Carl P. Decicco James

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)

添加到收藏夹
Article Chemistry, Medicinal

Discovery of pyrrolo[1,2-b]pyridazine-3-carboxamides as Janus kinase (JAK) inhibitors

James J. -W. Duan, Zhonghui Lu, Bin Jiang, Bingwei V. Yang, Lidia M. Doweyko, David S. Nirschl, Lauren E. Haque, Shuqun Lin, Gregory Brown, John Hynes, John S. Tokarski, John S. Sack, Javed Khan, Jonathan S. Lippy, Rosemary F. Zhang, Sidney Pitt, Guoxiang Shen, William J. Pitts, Percy H. Carter, Joel C. Barrish, Steven G. Nadler, Luisa M. Salter-Cid, Murray McKinnon, Aberra Fura, Gary L. Schieven, Stephen T. Wrobleski

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)

添加到收藏夹
Article Chemistry, Medicinal

N-in-1 dosing pharmacokinetics in drug discovery: Experience, theoretical and practical considerations

Kan He, Mingxin Qian, Harvey Wong, Stephen A. Bai, Bing He, Bernice Brogdon, James E. Grace, Baomin Xin, Jingtao Wu, Shelly X. Ren, Hang Zeng, Yuzhong Deng, Danielle M. Graden, Timothy V. Olah, Steve E. Unger, Joseph M. Luettgen, Robert M. Knabb, Donald J. Pinto, Patrick Y. S. Lam, James Duan, Ruth R. Wexler, Carl P. Decicco, David D. Christ, Scott J. Grossman

JOURNAL OF PHARMACEUTICAL SCIENCES (2008)

添加到收藏夹
Article Chemistry, Medicinal

Structure-based Discovery of Phenyl (3-Phenylpyrrolidin-3-yI)sulfones as Selective, Orally Active RORγt Inverse Agonists

James J. -W. Duan, Zhohghui Lu, Bin Jiang, Sylwia Stachura, Carolyn A. Weigelt, John S. Sack, Javed Khan, Max Ruzanov, Michael A. Galella, Dauh-Rurng Wu, Melissa Yarde, Ding-Ren Shen, David J. Shuster, Virna Borowski, Jenny H. Xie, Lisa Zhang, Sridhar Vanteru, Arun Kumar Gupta, Arvind Mathur, Qihong Zhao, William Foster, Luisa M. Salter-Cid, Percy H. Carter, T. G. Murali Dhar

ACS MEDICINAL CHEMISTRY LETTERS (2019)

添加到收藏夹
Article Chemistry, Medicinal

Rationally Designed, Conformationally Constrained Inverse Agonists of RORγt-Identification of a Potent, Selective Series with Biologic-Like in Vivo Efficacy

David Marcoux, James J. -W. Duan, Qing Shi, Robert J. Cherney, Anurag S. Srivastava, Lyndon Cornelius, Douglas G. Batt, Qingjie Liu, Myra Beaudoin-Bertrand, Carolyn A. Weigelt, Purnima Khandelwal, Sureshbabu Vishwakrishnan, Kumaravel Selvakumar, Ananta Karmakar, Arun Kumar Gupta, Mushkin Basha, Sridharan Ramlingam, Naveen Manjunath, Sridhar Vanteru, Sukhen Karmakar, Nageswara Maddala, Muthalagu Vetrichelvan, Anuradha Gupta, Richard A. Rainpulla, Arvind Mathur, Shiuhang Yip, Peng Li, Dauh-Rurng Wu, Javed Khan, Max Ruzanov, John S. Sack, Jinhong Wang, Melissa Yarde, Mary Ellen Cvijic, Sha Li, David J. Shuster, Virna Borowski, Jenny H. Xie, Kim W. McIntyre, Mary T. Obermeier, Aberra Fura, Kevin Stefanski, Georgia Cornelius, John Hynes, Joseph A. Tino, John E. Macor, Luisa Salter-Cid, Rex Denton, Qihong Zhao, Percy H. Carter, T. G. Murali Dhare

JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹
Article Chemistry, Medicinal

Discovery of BMS-986251: A Clinically Viable, Potent, and Selective RORγt Inverse Agonist

Robert J. Cherney, Lyndon A. M. Cornelius, Anurag Srivastava, Carolyn A. Weigelt, David Marcoux, James J-W Duan, Qing Shi, Douglas G. Batt, Qingjie Liu, Shiuhang Yip, Dauh-Rurng Wu, Max Ruzanov, John Sack, Javed Khan, Jinhong Wang, Melissa Yarde, Mary Ellen Cvijic, Arvind Mathur, Sha Li, David Shuster, Purnima Khandelwal, Virna Borowski, Jenny Xie, Mary Obermeier, Aberra Fura, Kevin Stefanski, Georgia Cornelius, Joseph A. Tino, John E. Macor, Luisa Salter-Cid, Rex Denton, Qihong Zhao, Percy H. Carter, T. G. Murali Dhar

ACS MEDICINAL CHEMISTRY LETTERS (2020)

添加到收藏夹
Article Chemistry, Medicinal

Discovery of (3S,4S)-3-methyl-3-(4-fluorophenyl)-4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxyprop-2-yl)phenyl)pyrrolidines as novel RORγt inverse agonists

Bin Jiang, James J. -W. Duan, Sylwia Stachura, Ananta Karmakar, Hemalatha Hemagiri, Dhanya Kumar Raut, Arun Kumar Gupta, Carolyn A. Weigelt, Javed Khan, John S. Sack, Dauh-Rurng Wu, Melissa Yarde, Ding-Ren Shen, Michael A. Galella, Arvind Mathur, Qihong Zhao, Luisa M. Salter-Cid, Percy H. Carter, T. G. Murali Dhar

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)

添加到收藏夹
Article Chemistry, Medicinal

Biologic-like In Vivo Efficacy with Small Molecule Inhibitors of TNFα Identified Using Scaffold Hopping and Structure-Based Drug Design Approaches

Hai-Yun Xiao, Ning Li, James J-W Duan, Bin Jiang, Zhonghui Lu, Khehyong Ngu, Joseph Tino, Lisa M. Kopcho, Hao Lu, Jing Chen, Andrew J. Tebben, Steven Sheriff, ChiehYing Y. Chang, Joseph Yanchunas, Deepa Calambur, Mian Gao, David J. Shuster, Vojkan Susulic, Jenny H. Xie, Victor R. Guarino, Dauh-Rurng Wu, Kurt R. Gregor, Christine B. Goldstine, John Hynes, John E. Macor, Luisa Salter-Cid, James R. Burke, Patrick J. Shaw, T. G. Murali Dhar

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹
Article Chemistry, Medicinal

Discovery of highly potent, selective, covalent inhibitors of JAK3

James Kempson, Damaso Ovalle, Junqing Guo, Stephen T. Wrobleski, Shuqun Lin, Steven H. Spergel, James J. -W. Duan, Bin Jiang, Zhonghui Lu, Jagabandhu Das, Bingwei V. Yang, John Hynes, Hong Wu, John Tokarski, John S. Sack, Javed Khan, Gary Schieven, Yuval Blatt, Charu Chaudhry, Luisa M. Salter-Cid, Aberra Fura, Joel C. Barrish, Percy H. Carter, William J. Pitts

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)

添加到收藏夹
Article Chemistry, Medicinal

Discovery of potent and efficacious pyrrolopyridazines as dual JAK1/3 inhibitors

John Hynes, Hong Wu, James Kempson, James J. -W. Duan, Zhonghui Lu, Bin Jiang, Sylwia Stachura, John S. Tokarski, John S. Sack, Javed A. Khan, Jonathan S. Lippy, Rosemary F. Zhang, Sidney Pitt, Guoxiang Shen, Kate Gillooly, Kim McIntyre, Percy H. Carter, Joel C. Barrish, Steven G. Nadler, Luisa M. Salter-Cid, Aberra Fura, Gary L. Schieven, William J. Pitts, Stephen T. Wrobleski

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)

添加到收藏夹
Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

添加到收藏夹
Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

添加到收藏夹
Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

添加到收藏夹
Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

添加到收藏夹
Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

添加到收藏夹
Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

添加到收藏夹
研讨会 海报 问题 讨论圈 基金 期刊 论文 科研社交 资讯集成 审稿人 关于我们 常见问题 移动App 隐私条款 使用条款
© Peeref 2019-2024. All rights reserved.